Search
PF-04447943
go.drugbank.com/drugs/DB11953InvestigationalPF-04447943 has been investigated for the treatment of Alzheimer's Disease.
PF-00446687
go.drugbank.com/drugs/DB12517InvestigationalPF-00446687 has been investigated for the treatment of Erectile Dysfunction.
PD-98059
go.drugbank.com/drugs/DB17042ExperimentalPD-98059 is an inhibitor of MAP-kinase kinase activation.[A253072]
Fasidotril
go.drugbank.com/drugs/DB20511ExperimentalThe usage of the INN stem '-tril/trilat' in the name indicates that Fasidotril is a endopeptidase inhibitor. Fasidotril has a monoisotopic molecular weight of 443.14 Da.
Clociguanil
go.drugbank.com/drugs/DB19775ExperimentalThe usage of the INN stem '-nil' in the name indicates that Clociguanil is a benzodiazepine receptor antagonist/agonist. Clociguanil has a monoisotopic molecular weight of 315.07 Da.
Safironil
go.drugbank.com/drugs/DB20553ExperimentalThe usage of the INN stem '-nil' in the name indicates that Safironil is a benzodiazepine receptor antagonist/agonist. Safironil has a monoisotopic molecular weight of 309.17 Da.
Inotuzumab ozogamicin
go.drugbank.com/drugs/DB05889ApprovedInvestigationalInotuzumab ozogamicin is an antibody-drug conjugate consisting of a humanized IgG4 kappa CD22-targeting monoclonal antibody covalently attached to calicheamicin derivative, N-acetyl-gamma-calicheamicin dimethylhydrazide. The antibody por...
Categories: P-glycoprotein substrates, P-glycoprotein substrates with a Narrow Therapeutic IndexLufironil
go.drugbank.com/drugs/DB20345ExperimentalThe usage of the INN stem '-nil' in the name indicates that Lufironil is a benzodiazepine receptor antagonist/agonist. Lufironil has a monoisotopic molecular weight of 281.14 Da.
Bretazenil
go.drugbank.com/drugs/DB21038ExperimentalThe usage of the INN stem '-nil' in the name indicates that Bretazenil is a benzodiazepine receptor antagonist/agonist. Bretazenil has a monoisotopic molecular weight of 417.07 Da.
PF-00217830
go.drugbank.com/drugs/DB12998InvestigationalPF-00217830 has been used in trials studying the treatment of Schizophrenia.